PMID- 29251166 OWN - NLM STAT- MEDLINE DCOM- 20190318 LR - 20190318 IS - 1029-2403 (Electronic) IS - 1026-8022 (Linking) VI - 59 IP - 9 DP - 2018 Sep TI - Expression of multiple leukemic stem cell markers is associated with poor prognosis in de novo acute myeloid leukemia. PG - 2144-2151 LID - 10.1080/10428194.2017.1410888 [doi] AB - Leukemic stem cells (LSCs) play a crucial role in chemotherapy resistance in acute myeloid leukemia (AML). Although the association between the expression of individual LSC markers and poor prognosis has been reported, few studies have evaluated the prognostic effect of multiple LSC markers in patients with AML. Herein, we examined three LSC markers (CD25, CD96, and CD123) and the combined effect of their expression on clinical outcome. We retrospectively analyzed 80 adult patients with de novo AML who received intensive chemotherapy. Multiple LSC marker expression was significantly associated with shorter three-year overall survival (OS), compared with single or no LSC marker expression (18.2 vs. 65.0%, p < .001). Multivariate analysis showed that the expression of multiple LSC markers remained significant in terms of three-year OS (hazard ratio: 3.80, p = .001). Therefore, the combined evaluation of several LSC markers can predict the clinical outcome in patients with AML. FAU - Yabushita, Tomohiro AU - Yabushita T AD - a Department of Hematology , Kobe City Medical Center General Hospital , Hyogo , Japan. FAU - Satake, Hironaga AU - Satake H AUID- ORCID: 0000-0001-7629-6803 AD - b Department of Medical Oncology , Kobe City Medical Center General Hospital , Hyogo , Japan. FAU - Maruoka, Hayato AU - Maruoka H AD - c Department of Clinical Laboratory , Kobe City Medical Center General Hospital , Hyogo , Japan. FAU - Morita, Mari AU - Morita M AD - a Department of Hematology , Kobe City Medical Center General Hospital , Hyogo , Japan. FAU - Katoh, Daisuke AU - Katoh D AUID- ORCID: 0000-0001-6576-0463 AD - a Department of Hematology , Kobe City Medical Center General Hospital , Hyogo , Japan. FAU - Shimomura, Yoshimitsu AU - Shimomura Y AD - a Department of Hematology , Kobe City Medical Center General Hospital , Hyogo , Japan. FAU - Yoshioka, Satoshi AU - Yoshioka S AD - a Department of Hematology , Kobe City Medical Center General Hospital , Hyogo , Japan. FAU - Morimoto, Takeshi AU - Morimoto T AD - d Clinical Research Center, Kobe City Medical Center General Hospital , Hyogo , Japan. AD - e Department of Clinical Epidemiology , Hyogo College of Medicine , Hyogo , Japan. FAU - Ishikawa, Takayuki AU - Ishikawa T AD - a Department of Hematology , Kobe City Medical Center General Hospital , Hyogo , Japan. LA - eng PT - Journal Article DEP - 20171218 PL - United States TA - Leuk Lymphoma JT - Leukemia & lymphoma JID - 9007422 RN - 0 (Antigens, CD) RN - 0 (Biomarkers, Tumor) RN - 0 (CD96 antigen) RN - 0 (Interleukin-2 Receptor alpha Subunit) RN - 0 (Interleukin-3 Receptor alpha Subunit) SB - IM MH - Acute Disease MH - Adolescent MH - Adult MH - Aged MH - Antigens, CD/metabolism MH - Antineoplastic Combined Chemotherapy Protocols/*therapeutic use MH - Biomarkers, Tumor/*metabolism MH - Female MH - Humans MH - Interleukin-2 Receptor alpha Subunit/metabolism MH - Interleukin-3 Receptor alpha Subunit/metabolism MH - Kaplan-Meier Estimate MH - Leukemia, Myeloid/*drug therapy/metabolism/pathology MH - Male MH - Middle Aged MH - Neoplastic Stem Cells/*drug effects/metabolism MH - Prognosis MH - Retrospective Studies MH - Young Adult OTO - NOTNLM OT - Acute myeloid leukemia OT - immunophenotypic studies OT - leukemic stem cell EDAT- 2017/12/19 06:00 MHDA- 2019/03/19 06:00 CRDT- 2017/12/19 06:00 PHST- 2017/12/19 06:00 [pubmed] PHST- 2019/03/19 06:00 [medline] PHST- 2017/12/19 06:00 [entrez] AID - 10.1080/10428194.2017.1410888 [doi] PST - ppublish SO - Leuk Lymphoma. 2018 Sep;59(9):2144-2151. doi: 10.1080/10428194.2017.1410888. Epub 2017 Dec 18.